41891-17-2

Basic information

• Product Name: N-(Chloroformyl)butylamine
• Synonyms: N-(Chloroformyl)butylamine;N-Butylcarbamoyl chloride
• CAS NO: 41891-17-2
• Molecular Formula: C₅H₁₀ClNO
• Molecular Weight: 0
• Mol File: 41891-17-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-(Chloroformyl)butylamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(Chloroformyl)butylamine(41891-17-2)
• EPA Substance Registry System: N-(Chloroformyl)butylamine(41891-17-2)

Safety Data

• Hazardous Substances Data: 41891-17-2(Hazardous Substances Data)

Usage

General Description

N-(Chloroformyl)butylamine is a chemical compound known for its reactivity features. Characterized by the formula C5H11ClNO, this organic compound holds potential for uses in several reactions due to its chloroformyl group. Although the specifics of its applications are not widely stated, its molecular structure suggests it could play roles in acid reactions, laboratory experimentation, or perhaps in chemical material synthesis. As with many other industrial chemicals, safety precautions should be taken to prevent unnecessary exposure, particularly avoiding inhalation or contact with eyes, skin, and clothing.

Upstream product

• 75-44-5 phosgene 
• 109-73-9 N-butylamine 
• 39078-72-3 S-methyl N-butylthiocarbamate 
• 32315-10-9 bis(trichloromethyl) carbonate 

Downstream Products

• 3149-00-6 phenbutamide 
• 552848-65-4 1-((2R,4aR,7R,8R,8aS)-6-Benzyloxy-8-hydroxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yl)-3-butyl-urea 
• 4299-07-4 2-butyl-1,2-benzothiazolin-3-one 
• 4107-40-8 N-Butyl-N'-phenoxyharnstoff 
• 1427196-00-6 butyl {6-[({[(Z)-(4-methyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate 
• 1427195-96-7 butyl {4-[({[(Z)-(4-methyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)(phenyl)methylene]amino}oxy)methyl]-1,3-thiazol-2-yl}carbamate 
• 54680-37-4 1-Butyl-1-nitroso-3-phenylharnstoff 
• 30287-38-8 N-butyl-N'-(4-hydrazinocarbonyl-benzenesulfonyl)-urea 
• 2224-10-4 Carboxytolbutamide 
• 339-43-5 carbutamide 
• 13738-74-4 3-(p-nitrobenzenesulfonyl)-1-butylurea 
• 24535-66-8 N-butyl-N'-(o-tolylsulfonyl)urea 
• 22486-31-3 Butyl-carbamic acid 4-[(4-ethoxy-phenylaminooxalyl)-amino]-phenyl ester 
• 67205-43-0 Butyl-carbamic acid 2,3,5-trichloro-4,6-dicyano-phenyl ester 

Relevant articles and documents

ISOXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PULMONARY DISEASES AND DISORDERS

The present disclosure features disclosed method of treating disorders such as COPD, bronchitis and/or asthma using disclosed compounds, optionally together with one or more additional active agents. Contemplated methods include administrating orally or by inhalation to a patient one or more disclosed compounds.

COMPOUNDS, COMPOSITIONS AND METHODS OF INCREASING CFTR ACTIVITY

The present disclosure features disclosed compounds which can increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells. The present disclosure also features methods of treating a condition associated with decreased CFTR activity or a condition associated with a dysfunction of proteostasis comprising administering to a subject an effective amount of a disclosed compound.

4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives

The present invention relates to compounds of formula I wherein R1 and R2 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.